Topics

  • Gout and crystal arthropathies: Investigation and new treatments
  • Is crystal arthropathy a local or systemic disease?
  • Large vessel vasculitis: Is imaging truly helpful in disease treatment and management?
  • Pulmonary complications of arthritis: What are they and how to treat?
  • Bone marrow transplants for the treatment of severe scleroderma: What have we learned?
  • Cardiovascular risks in inflammatory arthritis: Risk assessment and management in daily practice
  • Ultrasound in the management of inflammatory arthritis: Consensus or debate?
  • Who to choose for the management of arthritis: Rheumatologists or orthopaedic surgeons?
  • Randomized controlled trials: Design and analysis
  • Systemic lupus erythematosus: Biologic or non-biologic treatment?
  • Headache for rheumatologists: Pain and central sensitization syndrome
  • Use of biologics for rheumatoid arthritis treatment in countries without reimbursement: How do we address the needs of those patients?
  • Biosimilars: Old and new. What have we learned so far?
  • Which biologics are safe for tuberculosis and/or hepatitis C?
  • Biologics for the treatment of symptomatic osteoarthritis: Safer and more effective than NSAIDs and SySADOAS?
  • Tanezumab and osteoarthritis: Facts and rebirth
  • Intraarticular injections of corticosteroids, platelet rich plasma, and stem cells for osteoarthritis treatment: What to tell patients?
  • Metabolomics and osteoarthritis
  • Osteoporosis management for the rheumatologist: Western vs. Asian countries